The beauty industry is undergoing a profound transformation. Consumers are no longer interested solely in reducing the appearance of wrinkles or improving skin texture for a few hours. Increasingly, attention is shifting towards longevity, a concept that has already reshaped conversations around nutrition, medicine, fitness and wellness. The question is no longer simply how to look younger. It is how to support the biological mechanisms that help the body function better over time.
If biological age can differ significantly from chronological age, could the same principle apply to the skin?
According to a report by Fortune Business Insights, the global longevity and anti-ageing therapy market is projected to exceed US$44 billion by 2032 as scientific research continues to explore the biological processes associated with ageing. What was once considered a niche scientific field has rapidly entered mainstream consumer awareness, influencing everything from supplements and diagnostics to skincare.
This shift has changed the language of beauty itself. Terms such as regeneration, cellular health, resilience and biological age now appear alongside more familiar discussions of hydration and radiance. Consumers are becoming increasingly interested in understanding what happens beneath the skin’s surface and how scientific discoveries might help support healthier ageing. Few beauty houses have invested as heavily in this conversation as Lancôme. For decades, the brand has positioned scientific research as a central pillar of its skincare development. Yet its latest initiative signals a broader ambition. With Absolue Longevity MD, Lancôme moves beyond traditional anti-ageing narratives and enters the rapidly evolving field of longevity science. At the centre of this new chapter lies a simple but powerful idea: chronological age is fixed, but biological age is dynamic. While the calendar advances at the same pace for everyone, the condition of the body’s tissues and cells can vary significantly between individuals. The skin, as the body’s largest organ, often provides visible evidence of these differences.
Modern longevity research increasingly focuses on identifying the biological factors that contribute to ageing at a cellular level. Scientists now study biomarkers, cellular communication systems and energy production pathways in an effort to understand why some tissues age more efficiently than others. These discoveries are gradually influencing the beauty industry, which is beginning to adopt concepts previously associated with medical research.
Lancôme’s work in this area draws upon more than two decades of scientific investigation. Through its research programme, the company has studied 267 biomarkers associated with skin longevity, creating what it describes as a Longevity Wheel designed to better understand the mechanisms involved in skin ageing.
This research forms the foundation of Absolue Longevity MD. Rather than focusing exclusively on visible symptoms, the programme seeks to address some of the biological processes that influence the skin’s ability to maintain itself over time.
One of the most significant developments within the launch is Lancôme’s collaboration with the Swiss biotechnology company Timeline. The partnership introduces a proprietary molecule known as Mitopure™, developed after more than fifteen years of research and supported by over US$50 million in research and development investment. The science behind Mitopure™ centres on mitochondria. Often described as the power plants of cells, mitochondria are responsible for producing much of the energy required for cellular activity. Research suggests that mitochondrial efficiency tends to decline with age, affecting the ability of cells to repair, regenerate and maintain optimal function.
Mitopure™ is a highly purified form of Urolithin A, a molecule studied for its potential role in supporting mitophagy, the natural cellular process through which damaged mitochondria are removed and replaced. Scientists increasingly regard this recycling mechanism as an important component of healthy cellular ageing. Within the context of skincare, the goal is to help support the cellular energy systems that contribute to skin quality and resilience. By targeting processes associated with energy production, the technology seeks to address ageing from a different perspective than many traditional cosmetic ingredients.
The introduction of Mitopure™ marks the first time this technology has been made available on such a global scale through a luxury beauty brand. It also reflects the growing convergence between biotechnology and skincare, an area expected to become increasingly important over the coming years. Another notable aspect of Absolue Longevity MD is its recognition that ageing does not occur uniformly throughout life. Biological needs evolve over time, influenced by genetics, environment, lifestyle and individual physiology. As a result, Lancôme has developed three distinct intervention models designed to correspond with different stages of biological ageing.
Each routine combines Mitopure™ with additional proprietary active complexes calibrated to address specific skin concerns. This approach acknowledges that consumers increasingly seek personalised solutions rather than universal formulas. The era of one-size-fits-all skincare is gradually giving way to more targeted and individualised protocols. Importantly, Lancôme positions each routine as a complete system rather than a collection of interchangeable products. The formulations are designed to work together within their respective programmes and are not intended to be mixed across different biological-age categories. This reflects a broader movement towards protocol-based skincare, where effectiveness depends on the interaction between carefully selected steps.
The launch also highlights a larger trend reshaping luxury beauty. Increasingly, prestige skincare brands are drawing inspiration from disciplines once considered separate from cosmetics. Advances in biotechnology, longevity medicine, genomics and cellular biology are influencing product development in ways that would have seemed unlikely only a decade ago.
